Literature DB >> 17433912

The effect of cell-matrix interactions and aging on the malignant process.

Jacqueline Labat-Robert1, Ladislas Robert.   

Abstract

The malignant process, transformation of normal cells, proliferation, and metastasis formation, was considered as if originating from one single cell. Although the intrinsic mechanisms of transformation from the normal to the malignant state were both confirmed, an increasing body of evidence points to the surrounding matrix and cell-matrix interactions as major players in this process. Some of the most important arguments in favor of this contention are cited and commented in this chapter. Another important question concerns the relationship between the aging process and malignant transformation. A few decades ago, the frequency of clinically manifest tumors of several organs and tissues appeared to increase with age. As, however, average life expectancy increased rapidly over the last decades, clinical frequency of malignant tumors did not follow this tendency. It was argued that late in life the malignant process appears to decline. This justly inspired several teams to study the relationship between cellular senescence and malignant transformation. This is now an actively growing field which deserves special attention. Some of the pertinent experimental and theoretical arguments in favor of an antioncogene-mediated switch between these two processes are also reviewed with the caveat that this important and new subject of basic and clinical research on the malignant process is just at its beginning. It will certainly take an increasing importance during the coming years and decades with the hope to contribute to answer one of the most burning questions concerning the aging process: will life expectancy continue to increase linearly as predicted by some gerontologists, or will life expectancy level off or even decline as predicted by other epidemiologists. The relationship between cellular senescence and malignant transformation will play in this respect an important role.

Entities:  

Mesh:

Year:  2007        PMID: 17433912     DOI: 10.1016/S0065-230X(06)98007-5

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  8 in total

Review 1.  Fragments of extracellular matrix as mediators of inflammation.

Authors:  Tracy L Adair-Kirk; Robert M Senior
Journal:  Int J Biochem Cell Biol       Date:  2007-12-24       Impact factor: 5.085

Review 2.  Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells.

Authors:  Paul L Bollyky; Ben A Falk; Rebecca P Wu; Jane H Buckner; Thomas N Wight; Gerald T Nepom
Journal:  J Leukoc Biol       Date:  2009-04-28       Impact factor: 4.962

3.  Differential expression of extracellular matrix proteins in senescent and young human fibroblasts: a comparative proteomics and microarray study.

Authors:  Kyeong Eun Yang; Joseph Kwon; Ji-Heon Rhim; Jong Soon Choi; Seung Il Kim; Seung-Hoon Lee; Junsoo Park; Ik-Soon Jang
Journal:  Mol Cells       Date:  2011-05-11       Impact factor: 5.034

Review 4.  Cell senescence: role in aging and age-related diseases.

Authors:  Judith Campisi; Ladislas Robert
Journal:  Interdiscip Top Gerontol       Date:  2014-05-13

Review 5.  Aging-related alterations in the extracellular matrix modulate the microenvironment and influence tumor progression.

Authors:  Cynthia C Sprenger; Stephen R Plymate; May J Reed
Journal:  Int J Cancer       Date:  2010-10-08       Impact factor: 7.396

6.  An in vitro co-culture model of esophageal cells identifies ascorbic acid as a modulator of cell competition.

Authors:  Lauren M F Merlo; Rachelle E Kosoff; Kristin L Gardiner; Carlo C Maley
Journal:  BMC Cancer       Date:  2011-10-25       Impact factor: 4.430

7.  The role of manganese superoxide dismutase in skin aging.

Authors:  Nicolai Treiber; Pallab Maity; Karmveer Singh; Florentina Ferchiu; Meinhard Wlaschek; Karin Scharffetter-Kochanek
Journal:  Dermatoendocrinol       Date:  2012-07-01

8.  A Novel Prognostic Nomogram for Predicting Risks of Distant Failure in Patients with Invasive Breast Cancer Following Postoperative Adjuvant Radiotherapy.

Authors:  Yu Jin Lim; Sea-Won Lee; Noorie Choi; Jeanny Kwon; Keun-Yong Eom; Eunyoung Kang; Eun-Kyu Kim; Jee Hyun Kim; Yu Jung Kim; Se Hyun Kim; So Yeon Park; In Ah Kim
Journal:  Cancer Res Treat       Date:  2017-12-07       Impact factor: 4.679

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.